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During my career in biochemistry and clinical chemistry, three areas of activity
have been sources of great satisfaction. First among these is our usual function of
developing and supervising chemical laboratories that aid the medical profession in
diagnosis, prognosis, and treatment of disease. During 3 years wflh Prof. V. C.
Myers, at the State University of Iowa, and 19 years with Dr. F. W. Hartman, at
Henry Ford Hospflal, this was my principal assignment. Research was a secondary,
but by no means impossible or neglected, pursuit; in fact, many research interests
that continue to intrigue me developed during those years. Much of the work in
clinical laboratories can be classified as development, for it involves adapting known
principles and procedures to practical use; but fl also brings one into contact with
many challenging problems.
Even prosaic analytical duties may become exciting. One day at Iowa City,
everyone had diabetes. A l l blood sugar reports were held up while telephones
jangled and fermentation began at the clinical end of the line. Without my
knowledge, but with the best of intentions, the division of analytical chemistry had
made our laboratory a present of expensive and highly extracted filter paper, which
students in "quant" refused to buy at 2 cents a sheet, because some sheets broke
when folded. It was wefl known at the time that some of the cheapest grades of
filter paper contained only traces of reducing substances and prohibitive amounts
of phosphate, while some expensive grades were free of phosphate and full of
reducing substances.
Although not our principal function, identification of poisons, drugs, and ordinary
compounds available at the grocery or hardware store is often expected. While
this can be a waste of time or a frustrating venture, I can recall many instances in
which it disposed of unnecessary anxiety, exposed fraud, or even established the
cause of death. Knowing something about the circumstances may be eflher helpful
or misleading. An alkahne salt from a sack in the garage is obviously available in
sackfuls; our sample was sodium carbonate, and nothing to cause alarm. But the
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white powder which the life of the party took at 3 a.m. was not sodium bicarbonate,
as he supposed. It was lead arsenate, apparently selected with indifference from the
available packages. Most of the arsenic appeared in the urine, most of the lead in
the feces, and results of the mistake were not too serious. Another preparation,
thought to be apomorphine, turned out to be tartar emetic, the toxic effects of which
are cumulative; it should not have been put into a husband's coffee repeatedly to
cure him of alcoholism. A brand new distemper remedy, supposedly imported from
Europe, was pure lactose. Panaceas for human ifls can usually be disposed of
without analysis. I f analysis is demanded, it is a good rule to look for ingredients
that are more or less harmless and inexpensive.
A second field in which I have been privileged to participate is teaching. In
this connection, it might be wise to consider a situation that we may face in the
near future. In some highly respected departments of biochemistry, candidates for
the Ph.D. degree are no longer required to learn blood and urine analysis. Why
should they clutter up their minds with "old stuff" when there is such a wealth
of recent knowledge they must have if they are to survive as biochemists? Medical
students, on the other hand, are taught blood and urine analysis and are introduced
to a great deal of new material. So the M.D. of the near future wifl have background
information to set him thinking, and should be ready to consider recent as well as
long-established developments when he gets to the clinic. This is as it should be.
Should the prospective Ph.D.'s in biochemistry be denied contact with our
field that might be beneficial to it and to them? Should they be warned against
clinical chemistry as a purely routine pursuit in an area where chemists or biochemists who enter will be devoured by dragons? Such attitudes are not realistic.
Not long ago, the head of a well-known university department of biochemistry said
to me: "1 could replace any other member of my staff on short notice, but not
the clinical chemist." Perhaps clinical chemists who are willing and able to teach,
and who know the value and limitations of their field, could be useful in this
connection.
The theme that men in fields of applied science should participate in teaching
is receiving considerable attention in professional journals. An opportunity to do
so came to me in 1934, when the chemistry department of Wayne University (now
Wayne State University) asked me to start courses in general biochemistry and
biochemical methods of analysis. After devoting evenings to this for many years, I
consented to fill an unexpected vacancy in physiological chemistry, with intermediary
metabolism as my lecture topic — for the next 7 years. Many treasured associations
with faculty and students resulted, particularly with the eight candidates for the M.S.
degree and 5 for the Ph.D. degree, who completed their research requirements under
my supervision.
My third topic is research. During one of his frequent visits to our hospital,
the late Charles F. Kettering commented that he and his associates did a lot of
research that was published in the form of better automobiles. Many of us must
do a great deal of investigation of this type, but if one examines more formal
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publications it can be seen that quite a few are in three very interesting areas:
isolation and identification of compounds, methods of analysis, and metabolic problems.
Studies I have selected for discussion are in these areas.
A stimulating and provocative study by Behre and Benedict^ which appeared
in 1922, presented strong evidence for the absence of creatinine from normal blood.
From the Folin picric acid blood filtrate, kaolin did not remove the apparent
creatinine, whfle creatinine added to blood was transmitted to this filtrate and removed
by kaolin. My first paper on the topic of isolating creatinine^ begins with an erroneous
statement: "The use of kaolin in removing creatinine from dilute solutions is disadvantageous in that the absorbed creatinine can not be released again for identification." Benedict later told me that creatinine can be released from kaolin wflh
magnesium oxide suspension, and that this treatment also releases a chromogenic substance from kaolin with which a Folin picric acid filtrate of normal blood has been
shaken. Kaolin was, however, a bulky adsorbent.
In my first isolation procedures, creatinine was concentrated from blood filtrates
by adsorbing it on the potassium salt of a new complex acid^^ which we called
picrophosphotungstic acid, or on Lloyd's reagent.^" The base was then isolated as
creatinine potassium picrate. This was converted almost quantitatively to creatinine
zinc chloride, which was analyzed for nitrogen content per mifligram of creatinine.
Thus identification rested upon preparation and partial analysis of two derivatives.
Linneweh' modified one of our procedures, obtained the gold salt of creatinine from
beef blood, and submitted it to elementary analysis.
In subsequent studies'-' we used serum. Initial dflution was avoided by ultrafiltration, since precipitation technic had meanwhfle been improved so that creatinine
could be precipitated directiy from ultrafiltrate. Progress in precipitating creatinine
was the result of the activities of a series of investigators (Table 1). The solubility
of creatinine potassium picrate in water, which Jaffe^ recorded, calculates to 33.4 mg.
of creatinine per 100 ml. Morris' reduced this to 5.0 by saturating the supernatant
wflh picric acid. By adding an excess of potassium, Gaebler and Keltch^ reduced it
to 3.0, or even to 0.6, in initial precipitations in which contamination with potassium
picrate did not matter. Greenwald and Gross" studied the solubilities of double
picrates of creatinine with potassium, rubidium, and cesium, and found the one
with rubidium to be least soluble. By utflizing this information, and carrying out
precipitations in the refrigerator, we found that known creatinine could be precipitated so completely that less than 0.1 mg. per 100 ml. remained in the supernatant."
With this technic, creatinine was readily precipflated from ultrafiltrates of
normal human, dog, beef, and pig sera.' In isolation experiments on animal sera,
we used an ultrafilter that produced 200 ml. of ultrafiltrate from 300 ml. of serum
in 2 hours. Creatinine from beef serum and pig serum was readfly accumulated
and identified.' Creatinine from beef blood,^ dog blood," blood and transudate of
human nephritics,^ and dog blood obtained during experimental retention of various
types^'" had been identified previously.
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While these results were very tangible and gratifying, they did not completely
satisfy my curiosity. Our first isolation procedures,^ when applied to normal blood,
were inefficient enough to avoid serious conflict with evidence for absence of
creatinine from normal blood.' As our isolation methods improved," our troubles
increased, and when we began to wonder about the validity of the kaolin experiment,
it turned out that our precipitation method, under suitable conditions,'" could also
be used to precipitate added creatinine without precipitating the creatinine of normal
blood. To this day, I have the feeling that the story of creatinine in normal blood
is not fullv known.
iabic I
Conditions Affecting the completeness of Precipitation of Creatinine as a Double Picrate.
Solubility
ot creatinine
(mg./lOO ml.)
Creatinine potassium picrate
I n water (Jaffe, 8)
I n saturated picric acid (Morris, 9)
I n saturated picric acid, with potassium ion in excess
(Gaebler & Keltch, 3)

Rubidium creatinine picrate, (Greenwald and Gross, 10)
I n saturated picric acid, with Rb ion in excess temp. 5.0°C.
(Gaebler, 6)

1.21:1
1.36:1
1.51:1
3.0 :1

33.4
5,0
3.0
1.9
1.4
0.6

<0.1

It is, indeed, interesting that induced enzyme formation appeared on our
horizon during the resolution of this problem. Miller and Dubos'^ used a creatininedestroying enzyme, formed by soil bacteria grown on a medium in which creatinine
supplied the nitrogen, as a means of securing evidence for presence of creatinine in
blood. However, creatine was thought to be present as such in muscle from 1835
until 1929, when Fiske and SubbaRow" described their isolation studies on creatine
phosphate, existence of which could have been missed by a variety of "specific" methods.
Of several ventures into the field of analytical methods, determination of bromsulphalein" best illustrates the difference that appearance of photoelectric colorimeters
and spectrophotometers has made in our work, and the problem that differences in
design of the various instruments created.
Bromsulphalein (BSP) was formerly determined with a test tube comparator"
obtainable from the sellers of the indicator. That the color of alkaline BSP in
icteric sera could not be matched with the BSP standards was mentioned in several
papers. When examined in a Beckman spectrophotometer, the absorption spectra
of alkahne solutions of bflirubin and BSP are about as different as possible (Figure 1).
Although the eye is an amazing optical instrument and detects differences in wave
length as well as intensity, its "band pass" is arranged for outdoor purposes. Differences
in the band pass of various instruments also create a problem.
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Figure 1
Absorption spectra of bromsulphalein and bilirubin in 0,05N sodium hydroxide.

In one of our two procedures," we applied two-color spectrophotometry, which
enabled us to use a water blank, and reduced the amount of serum required to
0.5 ml. BSP concentration ( X ) was calculated from the absorbancies ( A J of the
solution at 580 mp. and 620 m/i as follows:

X =
0.0715

KiA,

A^'" — 1.2 AJ

— '^1

1.2
143

0.0715

A,^°°— 1.2 A /
0.0655

The absorbancy of BSP, per milligram, at 580 m/j,, with dilution, cefl depth, and
other conditions as specified, was 0.0715. In the spectral region between 620 and
580 m/i effects of tight scattering by normal or slightly turbid serum, and absorption
by hemoglobin or bilirubin, were smafl and similar. K i was the ratio of absorbancy
at 580 to absorbancy at 620 m^i, deriving from this composite source; K2 the
absorbancy ratio for BSP at same wave lengths.
Difficulties with this procedure arose when the Coleman Junior Spectrophotometer, with a band pass of about 35 m/x, was used. K2 was 14.3 when absorbancies
were determined with the Beckman instrument, which has a very narrow nominal
band width, and 3.7 when the Coleman Junior was employed. Small differences
in the average value of 1.2 for K i •A'cre unimportant when K2 was large, but
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significant when K2 was small. It was necessary to choose different wave lengths
for the Coleman Junior, or to use the alternative method of calibration given in our
paper (Eq. 2, Ref. 14). Newer procedures for determination of BSP have appeared""
and reference to my procedure has been made to fliustrate certain principles.
Since turbidity correction entered into two of our methods," " I may say that
the linear relationship between log of the absorbancy due to turbidity, and the negative
logarithm of wave length" has been confirmed with a number of Beckman instruments.
It does not apply for wave lengths in the near infrared, or when instruments with
wide band pass are used. The best correction for all interferences that can be avoided
is to avoid them. I f turbidity can not be avoided, one has a choice between correcting
for it by a method such as that which we used, or of decolorizing the substance to be
measured and subtracting the resufling blank."™
My interest in metabolic studies began while 1 was a candidate for the Ph.D.
degree at Toronto, and has been a continuing one. In their pioneer work on gigantism
in rats, Evans and Long^' used alkaline extracts of beef anterior pituitary. Putnam,
Benedict, and TeeF^ used it in simulating acromegaly in dogs. Teel salted out the
globulin fraction, which contained several anterior-lobe hormones. Such preparations
were made avaflable to me by members of the research staff of Parke, Davis & Company.
My first experiments,'^'" carried out in 1932, were so striking (Fig. 2) that I soon
developed a long term interest in metabolic effects of anterior-pituitary hormones.
When a dog receiving a constant amount of food increased its weight by 1 V2 lb. within
48 hours and stored quantities of nitrogen, in spite of an increase of more than 40
per cent in basal metabolic rate, it seemed to be high time to investigate! It was well
known that a similar increase in metabolic rate induced by intravenous thyroxin is
accompanied by marked losses of weight and nitrogen. There was, as usual, nothing
thermodynamically illegal about the behavior of our dog. The fall in nonprotein respiratory quotient was due to greatly increased oxidation of fat, not failure to oxidize
carbohydrate. Avaflable carbohydrate apparently ran low during the post-absorptive
period, since all of the extra calories could be supplied by carbohydrate if a sufficient
amount was added to the diet when the anterior pituitary preparation was given."
Nor was storage of nitrogen spurious. The nonprotein nitrogen of the blood,
as previously reported by Teel and Watkins," fell during such experiments, and we
found no change in fecal nitrogen. So began a long-term program with which we are still
occupied. Effects of growth hormone and corticotropin on nitrogen metabolism, and
the relationship of insulin to the latter effect, have been principal foci of our interest.
Highly purified growth hormone, assayed for residual impurities, has been made available to us by the Endocrine Study Section, National Institutes of Health. With this
preparation, we have verified our early finding^' that in depancreatized dogs receiving
a constant amount of food and insulin, nitrogen storage is not induced by growth
hormone but is induced if the insulin dose is increased when growth hormone is given."
We also found the purified growth hormone, which is virtually free of corticotropin,
as diabetogenic as earlier crude preparations in the depancreatized dog. Since diabet104
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Changes in nitrogen output, basal metabolic rate, nonprotein respiratory quotient, water intake,
urine volume, and weight in a normal bitch treated with crude growth hormone (G).

ogenic effects of crude preparations were mild in adrenalectomized depancreatized
dogs," there is further work ahead.
Morphologic and physiologic effects that endocrine glands exert upon one another,
as well as synergisms between products of these glands, create a rather complicated
situation. Nowhere is this better iflustrated than in the stubborn problem of calorigenesis, recently attacked with renewed vigor by Evans, Contopoulos, and Simpson,'"
and Evans, Simpson, and Evans." Transferring from the multiorgan level to the
subcellular ribonucleoprotein particle, one finds interesting studies on protein synthesis
and on effects of growth hormone by Balis et al.''' The pituitary will continue to
provide problems for many scientists for some time.
At our last previous scientific meeting, in Washington, D . C , 1 presented some
studies^' on effects of growth hormone and corticotropin on metabolism of N " from
glycine, alanine, and ammonium citrate. I will close with another study" that has not
been discussed with this group. Studies of Bartlett and Glynn," " Beaton et a/.," and
Zuchlewski and Gaebler"' indicated that growth hormone alters the activity of glutamic
oxalacetic transaminase in muscle, and particularly the glutamic pyruvic transaminase
in liver (see Fig. 4, Ref. 37). The profound reduction in activity of hepatic GPT
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naturafly aroused our interest in knowing whether the nitrogen transfer pattern
is altered.
In recent studies by Lees and Gaebler," each of four groups of hypophysectomized
rats received, by intraperfloneal injection, one of the four N'Mabeled amino acids —
glycine, L-alanine, L-aspartic acid, and L-glutamic acid. The groups were divided into
untreated control and growth-hormone-treated subgroups. Forty-eight hours after injection of the labeled amino acids, the animals were sacrificed. Proteins from the
myofibrfllar fraction of muscle were hydrolyzed, and 7 amino acids, as well as ammonia,
were isolated by column chromatography. Mass spectrometer determinations of N^^
excess in these compounds yielded several results of interest. The amino acids from
control groups, with the exception of threonine, were labeled. Alanine, glutamic acid,
and aspartic acid, as well as amide nitrogen received considerable amounts of N " .
When N'5-glycine was given, serine was heavily labeled. These findings are wefl known
in the case of normal rats; the point of interest is that nitrogen transfer was not
essentially altered in the absence of pituflary hormones. Growth hormone greatiy
increased the extent of incorporation of N^^ into the amino acids and amide nitrogen
of myofibrfllar protein, but did not afler the nitrogen transfer pattern.
While browsing in a book containing aphorisms of Sir Wflliam Osler,"° I came
upon the following: "One can get along with a few ounces of kidney and less liver
The liver is comparatively harmless and useless. It was put in merely for packing
purposes." No doubt, the last two quoted sentences were only meant to emphasize
the first one. I do not mean to imply that determination of tissue enzyme activflies is
a useless pursuit, on which my associates and many other investigators have wasted a
lot of time, but I do feel that if one can get along with so littie liver or kidney, the
significance of even large changes in tissue enzyme activflies must be considered with
caution. Whenever an experimental approach is possible, experiments with the substrates in question should be carried out.
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